Opinion|Videos|October 14, 2026

Treatment Sequencing and Closing Remarks

Explore how neoadjuvant therapy guides TGCT surgery timing, side-effect tradeoffs, and team-based decision-making for locally advanced disease without rushing into operations.

Panelists then proceed to discuss treatment sequencing and the patients they see in real practice compared to clinical trials. One panelist delves into his understanding and opinions on neoadjuvant care in his practice setting. The panelists then proceed to discuss their takeaways from their discussion during this program. They emphasize the importance of a multidisciplinary team and the patient’s experience. The panelists provide closing remarks and finish the conversation.

Related to this article